Exponent, Inc. - Common Stock (EXPO)
82.24
-0.36 (-0.44%)
Exponent Inc is a multidisciplinary engineering and scientific consulting firm that provides expert solutions to complex technical challenges
The company specializes in a variety of fields, including engineering, environmental science, and health sciences, offering a blend of advisory services, research, and analysis to help clients navigate issues related to product design, safety, and performance. With a team of professionals that includes engineers, scientists, and researchers, Exponent assists clients across diverse industries, from automotive to biotechnology, in making informed decisions based on robust data analysis and expertise in various technical disciplines.
Exponent’s stock price has taken a beating over the past six months, shedding 26.7% of its value and falling to $81.90 per share. This may have investors wondering how to approach the situation.
Via StockStory · March 19, 2025
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · March 18, 2025
A fundamental analysis of (NASDAQ:EXPO): Should you consider EXPONENT INC (NASDAQ:EXPO) for quality investing?
Via Chartmill · March 14, 2025
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution.
While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Via StockStory · March 13, 2025

Customers are cutting back due to economic uncertainty.
Via The Motley Fool · February 2, 2024

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how business process outsourcing & consulting stocks fared in Q4, starting with Huron (NASDAQ:HURN).
Via StockStory · March 12, 2025

EXPO stock results show that Exponent beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 25, 2024

Explore why these three industrial stocks are currently overvalued and why selling them before the end of July could be a smart move.
Via InvestorPlace · July 22, 2024

Exponent soars on impressive Q1 FY24 results, with sales surging 3.3% YoY to $144.933M, outperforming estimates. Engineering and scientific services dominate revenue, comprising 84% of Q1 earnings, showcasing robust growth.
Via Benzinga · April 26, 2024

Via Benzinga · April 26, 2024

Via Benzinga · April 26, 2024

Via Benzinga · April 26, 2024

EXPO stock results show that Exponent beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · April 25, 2024

Via Benzinga · April 25, 2024

Via Benzinga · February 1, 2024

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.
Via Benzinga · February 2, 2024

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on revenue of $75.66 billion.
Via Benzinga · February 1, 2024

Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.
Via Benzinga · October 27, 2023